This inventor holds 4 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignees: Bi Pharma Kg., Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2004-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mainz, DE (2004 - 2005)
- Attenweiler, DE (2005 - 2013)
Company Filing History:
1 out of 1 
1 out of 1,561 
1 out of 194 
Years Active: 2004-2013
Title: The Innovative Journey of Inventor Christian Kulinna
Introduction
Christian Kulinna, an accomplished inventor based in Attenweiler, Germany, has made notable contributions to the field of pharmaceuticals with a focus on chemically synthesized compounds. With a total of four patents to his name, Kulinna's work continues to influence the development of essential pharmaceutical substances.
Latest Patents
Kulinna's latest patents highlight his expertise in preparing amino crotonyl compounds. One significant patent details an improved process for preparing the compound 4-[(3-chloro-4-fluorophenyl)amino]-6-{[4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino}-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline and its related aminocrotonyl compounds. This patent also includes a method for preparing a suitable salt of the aforementioned compound for use as a pharmaceutically active substance. Additionally, he holds a patent for crystalline tiotropium bromide monohydrate, along with processes for its preparation, pharmaceutical compositions, and their applications.
Career Highlights
Throughout his career, Christian Kulinna has made significant strides in the field of pharmaceutical chemistry. He has worked with prestigious companies, including Boehringer Ingelheim Pharma KG and Bi Pharma KG, where he honed his skills and applied his knowledge to groundbreaking projects. His innovative approaches have paved the way for the development of new medications.
Collaborations
During his professional journey, Kulinna has had the opportunity to collaborate with notable colleagues, including Rolf Banholzer and Peter Sieger. These collaborations have enriched his work and contributed to the successful development of innovative pharmaceutical solutions.
Conclusion
Christian Kulinna stands out as a prominent inventor in the pharmaceutical sector. With his remarkable patents and collaborations, he continues to make significant contributions that advance medical science and improve patient care. His dedication to innovation exemplifies the critical role inventors play in shaping the future of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile